BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35163323)

  • 1. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
    Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
    Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
    Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
    Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
    Front Immunol; 2019; 10():2156. PubMed ID: 31572374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
    Hauser MA; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
    Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
    J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
    Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
    J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
    Haessler U; Pisano M; Wu M; Swartz MA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
    Artinger M; Gerken OJ; Legler DF
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR7 Sulfotyrosine Enhances CCL21 Binding.
    Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.
    Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT
    Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis.
    Oliveira-Neto HH; de Souza PP; da Silva MR; Mendonça EF; Silva TA; Batista AC
    Tumour Biol; 2013 Feb; 34(1):65-70. PubMed ID: 22976543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
    Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
    Database (Oxford); 2015; 2015():. PubMed ID: 26504105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.
    Nandagopal S; Wu D; Lin F
    PLoS One; 2011 Mar; 6(3):e18183. PubMed ID: 21464944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.
    Lee J; Park C; Kim HJ; Lee YD; Lee ZH; Song YW; Kim HH
    Exp Mol Med; 2017 Jul; 49(7):e358. PubMed ID: 28729639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
    Jørgensen AS; Rosenkilde MM; Hjortø GM
    Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.
    Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS
    Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
    Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
    Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
    Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
    J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.